| Income Statement | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Interest expense | - | - | 849,538 | 752,075 |
| Net loss before income taxes | -690,913 | -671,977 | -1,229,154 | -1,561,768 |
| Income taxes note 3 | - | 0 | - | - |
| Net loss before dividends | -690,913 | -671,977 | -1,229,154 | -1,561,768 |
| Preferred stock dividends | 81,410 | 82,316 | 89,392 | 91,261 |
| Deemed dividends note 9 | - | 0 | - | - |
| Net loss attributable to common stocklholders | -772,323 | -754,293 | -1,318,546 | -1,653,029 |
| Translation adjustment | 9,286 | -36,169 | 76,680 | -129,376 |
| Comprehensive loss | -763,037 | -790,462 | -1,241,866 | -1,782,405 |
| Loss per share, basic | -0.029 | -0.029 | -0.054 | -0.073 |
| Loss per share, diluted | -0.029 | -0.029 | -0.054 | -0.073 |
| Weighted average number of common shares outstanding - basic | 26,767,370 | 26,284,734 | 24,232,369 | 22,493,626 |
| Weighted average number of common shares outstanding - diluted | 26,767,370 | 26,284,734 | 24,232,369 | 22,493,626 |
BIOTRICITY INC. (BTCY)
BIOTRICITY INC. (BTCY)